269 results on '"Moore, Ian N."'
Search Results
2. A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters
3. Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in macaques
4. Chitinase 3-like 1 is a profibrogenic factor overexpressed in the aging liver and in patients with liver cirrhosis
5. Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine
6. CAF08 adjuvant enables single dose protection against respiratory syncytial virus infection in murine newborns
7. Intranasal immunization with avian paramyxovirus type 3 expressing SARS-CoV-2 spike protein protects hamsters against SARS-CoV-2
8. A nonhuman primate model for genital herpes simplex virus 2 infection that results in vaginal vesicular lesions, virus shedding, and seroconversion.
9. mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates
10. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses
11. Broadly neutralizing antibody induction by non-stabilized SARS-CoV-2 Spike mRNA vaccination in nonhuman primates
12. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
13. Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure
14. Chlamydia evasion of neutrophil host defense results in NLRP3 dependent myeloid-mediated sterile inflammation through the purinergic P2X7 receptor
15. Pathogenesis and outcome of VA1 astrovirus infection in the human brain are defined by disruption of neural functions and imbalanced host immune responses
16. Investigation of the impact of clonal hematopoiesis on severity and pathophysiology of COVID-19 in rhesus macaques
17. Host resistance to pulmonary Mycobacterium tuberculosis infection requires CD153 expression
18. Attenuated activation of pulmonary immune cells in mRNA-1273-vaccinated hamsters after SARS-CoV-2 infection
19. Lethal CD4 T Cell Responses Induced by Vaccination Against Staphylococcus aureus Bacteremia
20. Live-attenuated pediatric parainfluenza vaccine expressing 6P-stabilized SARS-CoV-2 spike protein is protective against SARS-CoV-2 variants in hamsters
21. Anophelessalivary apyrase regulates blood meal hemostasis and drives malaria parasite transmission
22. Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in non-human primates
23. Figure S3 from Molecular Signature and Mechanisms of Hepatitis D Virus–Associated Hepatocellular Carcinoma
24. Data from Molecular Signature and Mechanisms of Hepatitis D Virus–Associated Hepatocellular Carcinoma
25. Human norovirus targets enteroendocrine epithelial cells in the small intestine
26. A primate model of severe malarial anaemia: a comparative pathogenesis study
27. Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in nonhuman primates.
28. TNF overproduction impairs epithelial staphylococcal response in hyper IgE syndrome
29. Epithelial-intrinsic defects in TGFβR signaling drive local allergic inflammation manifesting as eosinophilic esophagitis
30. Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)–Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection
31. Live-attenuated pediatric parainfluenza vaccine expressing 6P-stabilized SARS-CoV-2 spike protein is protective against SARS-CoV-2 variants in hamsters
32. Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeys
33. Commercial influenza vaccines vary in both the structural arrangements of HA complexes and in induction of antibodies to cross-reactive HA epitopes
34. Imbalanced immune response and dysregulation of neural functions underline fatal opportunistic encephalitis caused by astrovirus
35. A spike-modified Middle East respiratory syndrome coronavirus (MERS-CoV) infectious clone elicits mild respiratory disease in infected rhesus macaques
36. Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccines
37. An intranasally administrated SARS-CoV-2 beta variant subunit booster vaccine prevents beta variant replication in rhesus macaques
38. Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine candidate is protective in macaques
39. mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron
40. mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron
41. Breadth of SARS-CoV-2 Neutralization and Protection Induced by a Nanoparticle Vaccine
42. Intranasal Pediatric Parainfluenza Virus-Vectored SARS-CoV-2 Vaccine Candidate Is Protective in Macaques
43. Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung
44. Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine–boosted nonhuman primates
45. Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airway
46. An intranasally administrated SARS-CoV-2 beta variant subunit booster vaccine prevents beta variant viral replication in rhesus macaques
47. Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates
48. Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates
49. Protection against SARS-CoV-2 Beta Variant in mRNA-1273 Boosted Nonhuman Primates
50. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.